Personalized Preclinical Trials in BRAF Inhibitor–Resistant Patient-Derived Xenograft Models Identify Second-Line Combination Therapies-Reference-Cited by-同舟云学术

Personalized Preclinical Trials in BRAF Inhibitor–Resistant Patient-Derived Xenograft Models Identify Second-Line Combination Therapies

Published:2015-12-16 Issue:7 Volume:22 Page:1592-1602
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Krepler Clemens,Xiao Min,Sproesser Katrin,Brafford Patricia A.,Shannan Batool,Beqiri Marilda,Liu Qin,Xu Wei,Garman Bradley,Nathanson Katherine L.,Xu Xiaowei,Karakousis Giorgos C.,Mills Gordon B.,Lu Yiling,Ahmed Tamer A.,Poulikakos Poulikos I.,Caponigro Giordano,Boehm Markus,Peters Malte,Schuchter Lynn M.,Weeraratna Ashani T.,Herlyn Meenhard

Funder

CCSG

NIH

CCSGDr. Miriam and Sheldon G. Adelson Medical Research Foundation

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving Water Solubility and Skin Penetration of Ursolic Acid through a Nanofiber Process to Achieve Better In Vitro Anti-Breast Cancer Activity;Pharmaceutics;2024-08-29

2. Patient-derived melanoma models;Pathology - Research and Practice;2024-07

3. scNovel: a scalable deep learning-based network for novel rare cell discovery in single-cell transcriptomics;Briefings in Bioinformatics;2024-03-27

4. Harnessing the potential of reverse‐phase protein array technology: Advancing precision oncology strategies;Cancer Science;2024-02-26

5. Advancements in the ERK1/2 Signaling Pathway Affecting Male Reproduction;Frontiers in Bioscience-Landmark;2024-01-18